Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.

× No keyword cloud information.

22 in total

1. Topiramate augmentation in a patient with obsessive-compulsive disorder.

Authors: Michael Van Ameringen; Beth Patterson
Journal: J Psychiatry Neurosci Date: 2015-09 Impact factor: 6.186

Review 2. Pharmacological treatment of obsessive-compulsive disorder.

Authors: Christopher Pittenger; Michael H Bloch
Journal: Psychiatr Clin North Am Date: 2014-07-24

Review 3. Anticonvulsants in anxiety disorders.

Authors: Gustavo Kinrys; Lisa E Wygant
Journal: Curr Psychiatry Rep Date: 2005-08 Impact factor: 5.285

Review 4. HCN Channel Targets for Novel Antidepressant Treatment.

Authors: Stacy M Ku; Ming-Hu Han
Journal: Neurotherapeutics Date: 2017-07 Impact factor: 7.620

5. Does gabapentin lead to early symptom improvement in obsessive-compulsive disorder?

Authors: Emin Onder; Umit Tural; Mehmet Gökbakan
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2008-02-23 Impact factor: 5.270

Review 6. Antiepileptic drugs in the treatment of anxiety disorders: role in therapy.

Authors: Michael Van Ameringen; Catherine Mancini; Beth Pipe; Mark Bennett
Journal: Drugs Date: 2004 Impact factor: 9.546

Review 7. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors: Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal: BMC Psychiatry Date: 2014-07-02 Impact factor: 3.630

Review 8. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.

Authors: Christopher Pittenger; John H Krystal; Vladimir Coric
Journal: NeuroRx Date: 2006-01

9. The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic.

Authors: Jeffrey R Strawn; Thomas D Geracioti
Journal: Neuropsychiatr Dis Treat Date: 2007-04 Impact factor: 2.570

10. Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors: Jonathan T Ting; Guoping Feng
Journal: Curr Chem Genomics Date: 2008-01-01